Whatever the etiology, some extreme views come very close to the behaviors of bipolar mania, as illustrated in a recent documentary.
James Phelps, MD
Let us look at two major trends in our evolving understanding of this complex mood disorder and its treatment, to wrap up 2018 and to consider the year ahead.
Three simple steps may better align your practice with available data on the efficacy and safety of thyroid supplementation in physiologic doses.
Dr Phelps puts thyroid dysfunction into clinical context for patients with comorbid mood disorders.
Old data have recently been gathered and systematically presented—reinforced by a new study, but perhaps contradicted by another. So it’s time to revisit this story.
A rare but serious reaction to this treatment can have immunological consequences. As with all medications, however, the latest alert does not change how psychiatrists manage the risks.
How many people who take an antidepressant truly have severe difficulties when they try to taper off? Or, is it “all in their mind”?
When the treatment doesn’t work, consider the options. Or, question your diagnosis.
Transcranial direct current stimulation delivery systems differ from one another in design, action, and results. One has been shown to be significantly better than sham treatment for bipolar depression. What does this mean for clinical practice?
This statin shows promise in reducing symptoms of bipolar disorder and depression. Still, one must be cautious and think through the treatment plan for each patient.